Administration of intrauterine Misoprostol in decreasing the blood loss in cesarean sectio
Not Applicable
Completed
- Conditions
- Health Condition 1: O679- Intrapartum hemorrhage, unspecified
- Registration Number
- CTRI/2023/03/050948
- Lead Sponsor
- Aiims Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1.18-35 yesar age
2.singleton pregnancy
3.37-40 week POG
4.no h/o coagulopathy
5.no h/o hypersensitivity to prostaglandins
6.consento participate in study
Exclusion Criteria
1.Preterm or post term Pregnancy
2.Grandmultipara( >5 Pregnancy)
3.H/o Coagulopathy
4.H/o hypersensitivity to Prostaglandins
5.Risk of Obstetric Hemmorhhage
6.H/O Anemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To estimate of the amount of blood loss during and within 24 hour of caesarean delivery following administration of intrauterine misoprostol plus intravenous oxytocin compared to intravenous oxytocin alone.Timepoint: from the delivery of the delivery of the baby till the 24 hours after the cesarean section
- Secondary Outcome Measures
Name Time Method Incidence of PPH <br/ ><br>Side effects of Tab.Misoprostol <br/ ><br>Need of Blood TransfusionTimepoint: 18 month